… The discovery of epitope is a key first step in antigen-targeted immunotherapy against viral
… decade, particularly in the light of antiviral immunotherapy (27). The current strategy mainly …

… -2 protein may interact with the LMP-1 of EBV upon internalization of SARS-CoV-2 into the
cell to … of SARS-CoV-2 may bind to PD-1, similar to the targeted mAb drugs pembrolizumab or …

… SARS-CoV-2 in health care, most prominently in vaccine development. However, why some
people infected with SARS-CoV-… the host immune response to SARS-CoV-2. Unsurprisingly, …

… , Commentaries) covering various developments, trends, and advances in discovering
effective vaccines and immunotherapies for SARS-CoV-2/COVID-19 along with presenting the …

… Indicated are the time of discovery or first description for corticosteroids, interferons, IL-2,
IL-… with their successful uses in humans as immunotherapies for the indicated non-infectious …

… Later, it was discovered that an essential proteolytic cleavage event takes … SARS-CoV-2
to some extent (85). These epitopes could be a promising factor in developing immunotherapy …

… Coronaviruses, including the newly discovered SARS-CoV-2, are spherical single-stranded
RNA viruses, characterized by spike proteins, projecting from the virion surface. The …

… are receiving immunotherapy. Uncertainty remains about whether immunotherapies increase
the risk of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or …

… The discovery of therapy reagents for treating COVID-19 are urgently needed, and the …
g–i footprint of a representative antibody from the Coronavirus Immunotherapeutic Consortium (…

… discovered to play a role in the development of the ACE2-… targeting various epitopes on the
SARS CoV-2 spike protein … conserved regions within the SARS CoV and SARS CoV-2 spike …